Chromadex Corp Stock
Chromadex Corp Stock
Chromadex Corp took a tumble today and lost -€0.220 (-4.960%).
Our community is currently high on Chromadex Corp with 5 Buy predictions and 0 Sell predictions.
With a target price of 10 € there is potential for a 136.97% increase which would mean more than doubling the current price of 4.22 € for Chromadex Corp.
Our community identified positive and negative aspects for Chromadex Corp stock for the coming years. 0 users see the criterium "EBIT Margin" as a plus for the Chromadex Corp stock. On the other hand our users think that "EBIT Margin" could be a problem in the future.
Pros and Cons of Chromadex Corp in the next few years
Pros
?
C******** o* t** e**********
?
S********** s********
?
B****
Cons
?
M***** P*******
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Chromadex Corp vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Chromadex Corp | -4.960% | -12.448% | -0.472% | -40.979% | -23.273% | 193.361% | -56.495% |
| Intellia Therapeutics Inc | -0.890% | -2.027% | 13.395% | 26.020% | 42.390% | -67.037% | -79.688% |
| Cardio3 Biosciences S.A. | 0.000% | -12.500% | 97.183% | -45.419% | 107.407% | -72.056% | -95.556% |
| Polynovo Ltd | 6.190% | 11.111% | 15.385% | -8.397% | -11.765% | -54.887% | -65.116% |
Comments
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat
ChromaDex Co. (NASDAQ: CDXC) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Show more
Ratings data for CDXC provided by MarketBeat